Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 665

Similar articles for PubMed (Select 19303506)

1.

Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.

Marder VJ.

Thromb Res. 2009;123 Suppl 4:S56-61. doi: 10.1016/S0049-3848(09)70145-8. Review.

PMID:
19303506
2.

Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.

Marder VJ, Landskroner K, Novokhatny V, Zimmerman TP, Kong M, Kanouse JJ, Jesmok G.

Thromb Haemost. 2001 Sep;86(3):739-45.

PMID:
11583303
3.

Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.

Razavi MK, Wong H, Kee ST, Sze DY, Semba CP, Dake MD.

J Endovasc Ther. 2002 Oct;9(5):593-8.

PMID:
12431142
4.

Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding.

Sadeghi S, Marder VJ, Stewart D, Kong M, Humphries J, Baumbach GA, Jesmok G.

J Thromb Haemost. 2003 Dec;1(12):2621-5.

PMID:
14675099
5.

Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.

Ouriel K, Katzen B, Mewissen M, Flick P, Clair DG, Benenati J, McNamara TO, Gibbens D.

J Vasc Interv Radiol. 2000 Jul-Aug;11(7):849-54.

PMID:
10928520
6.

Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?

Novokhatny VV, Jesmok GJ, Landskroner KA, Marder VJ, Zimmerman TP.

Trends Pharmacol Sci. 2004 Feb;25(2):72-5. Review.

PMID:
15102492
7.

Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential.

Marder VJ, Novokhatny V.

J Thromb Haemost. 2010 Mar;8(3):433-44. doi: 10.1111/j.1538-7836.2009.03701.x. Epub 2009 Nov 23. Review.

PMID:
19943877
8.

Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.

Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ.

Blood. 2003 Apr 15;101(8):3002-7. Epub 2002 Nov 21.

9.

Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.

Marder VJ, Comerota AJ, Shlansky-Goldberg RD, Davis JP, Deng C, Hanna K, Fineberg D.

J Thromb Haemost. 2012 Jun;10(6):985-91. doi: 10.1111/j.1538-7836.2012.04728.x.

PMID:
22487025
10.

Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.

Safieddine N, Mamazza J, Common A, Prabhudesai V.

Can J Surg. 2007 Feb;50(1):68-9. No abstract available.

11.

Thrombolysis in deep vein thrombosis: is there still an indication?

Wells PS, Forster AJ.

Thromb Haemost. 2001 Jul;86(1):499-508.

PMID:
11487040
12.
13.

Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.

Skeik N, Gits CC, Ehrenwald E, Cragg AH.

Vasc Endovascular Surg. 2013 Oct;47(7):519-23. doi: 10.1177/1538574413497107. Epub 2013 Jul 29.

PMID:
23899656
14.

[Role of plasminogen activators in the treatment of deep venous thrombosis].

Bollaert PE.

Ann Cardiol Angeiol (Paris). 2002 Jun;51(3):169-71. Review. French.

PMID:
12471649
15.

Late results of catheter-directed recombinant tissue plasminogen activator fibrinolytic therapy of iliofemoral deep venous thrombosis.

Casella IB, Presti C, Aun R, Benabou JE, Puech-Leão P.

Clinics (Sao Paulo). 2007 Feb;62(1):31-40.

16.

Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.

Hoefer IE, Stroes ES, Pasterkamp G, Levi MM, Reekers JA, Verhagen HJ, Meijers JC, Humphries JE, Rotmans JI.

J Vasc Interv Radiol. 2009 Jul;20(7):951-8. doi: 10.1016/j.jvir.2009.03.043. Epub 2009 May 28.

PMID:
19481472
17.

Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.

Kim HS, Preece SR, Black JH, Pham LD, Streiff MB.

J Vasc Surg. 2008 Feb;47(2):388-94. doi: 10.1016/j.jvs.2007.10.033.

18.

Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5.

Marder VJ, Manyak S, Gruber T, Goyal A, Moreno G, Hunt J, Bromirski J, Scuderi P, Petteway SR Jr, Novokhatny V.

Thromb Haemost. 2010 Oct;104(4):780-7. doi: 10.1160/TH09-10-0742. Epub 2010 Aug 30.

PMID:
20806125
19.

Intra-arterial thrombolysis of complete deep cerebral venous thrombosis.

Liebetrau M, Mayer TE, Bruning R, Opherk C, Hamann GF.

Neurology. 2004 Dec 28;63(12):2444-5. No abstract available.

PMID:
15623729
20.

Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.

Gelabert HA, Jimenez JC, Rigberg DA.

Ann Vasc Surg. 2007 Mar;21(2):149-54.

PMID:
17349354
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk